Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Weidinger

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Acta Dermato-Venereologica|March 1, 1997
Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profileH Meffert, M Bräutigam, L Färber, et al.
Arzneimittel-Forschung|January 1, 1983
[Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients]R Mies, R Lang, G Weidinger, et al.
Journal of the American Academy of Dermatology|March 22, 2000
A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of lifeW Czech, M Bräutigam, G Weidinger, et al.
Cardiovascular Drugs and Therapy|March 1, 1997
Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertensionG Bönner, R Schmieder, R Chrosch, et al.
Archives of Dermatology|August 1, 1995
Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study GroupH Hofmann, M Bräutigam, G Weidinger, et al.
Mechanisms of Development|May 12, 1998
Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2F Aberger, G Weidinger, H Grunz, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1992
Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal functionW Kirch, A Nokhodian, A Halabi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Treatment of patients initially for acute deep vein thrombosis with a low-molecular-weight heparin at a fixed, body weight-independent dosageJ Harenberg, H Riess, J Brom, et al.
Journal of Virology|March 10, 2001
Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles virus-induced encephalitisG Weidinger, G Henning, V ter Meulen, et al.
The British Journal of Dermatology|May 1, 1997
Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study GroupI Tausch, M Bräutigam, G Weidinger, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Acta Dermato-Venereologica|March 1, 1997
Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profileH Meffert, M Bräutigam, L Färber, et al.
Arzneimittel-Forschung|January 1, 1983
[Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients]R Mies, R Lang, G Weidinger, et al.
Journal of the American Academy of Dermatology|March 22, 2000
A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of lifeW Czech, M Bräutigam, G Weidinger, et al.
Cardiovascular Drugs and Therapy|March 1, 1997
Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertensionG Bönner, R Schmieder, R Chrosch, et al.
Archives of Dermatology|August 1, 1995
Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study GroupH Hofmann, M Bräutigam, G Weidinger, et al.
Mechanisms of Development|May 12, 1998
Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2F Aberger, G Weidinger, H Grunz, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1992
Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal functionW Kirch, A Nokhodian, A Halabi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Treatment of patients initially for acute deep vein thrombosis with a low-molecular-weight heparin at a fixed, body weight-independent dosageJ Harenberg, H Riess, J Brom, et al.
Journal of Virology|March 10, 2001
Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles virus-induced encephalitisG Weidinger, G Henning, V ter Meulen, et al.
The British Journal of Dermatology|May 1, 1997
Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study GroupI Tausch, M Bräutigam, G Weidinger, et al.
Pageof 9